Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.
Apologies I missed it mate.
To be honest, it doesn’t matter what we think, you are right markets do what they like when they like, and all it’s takes is a big buyer/ seller or good/ bad news to completely destroy anyone’s prediction.
Whatever this does in the very short term, I know it will be higher in the coming weeks for sure.
It hasn’t taken a dive HK, just usual and predictable retrace. It’s happened many times on the way up. Nothing goes up in a straight line.
But partly agree with you HK in that some are not balanced on here. Earlier when I said looks like we might get a little retrace as usual, TB was first to jump and write the exact opposite to what I wrote haha.
The thing is I don’t disagree with TB in that I believe this will overall continue on upward trend until results. But the facts are that nothing goes up in a straight line. It hasn’t so far and it won’t in future. So TB doesn’t need to get offended or feel the need to constantly counter anything that’s not 1000% bullish, because I am only talking temporary dips, totally normal...
Charts are not 100%, neither am I an expert, but they do give indications!
Optimism is not what I invest on. This drug like many has potential, not doubting that one bit.
But the facts are it needs cash, approx 7-10m will be a good start. If they sell the gold shares that would be great as there not in the companies business interest anymore. But this is up to the directors not us.
The alternative is serious dilution at a large discount, like all small aim companies, including FUM.
Just look at FUM and see its price action over the past couple years. 20p, £1, 50p, 5p, now 45p. It went down to 5p on funding lol. OVB will not be much different in its journey.
FUM are now at the last hurdles with Ph3 trails, which could go anyway let’s be honest. But until it’s results come out in Nov/Dec it will be on an upward trend, like it has been for past 6 months, with small retraces on the way.
OVB will get there as well, but funding, dilution, probable phase2b trails needed for EU & US before they will get to even start phase 3 trails for eu/us. Remember EU/US are the main markets!
This may continue to rise, no one can guess where it will go or not. But the concerns above need to be addressed as well.
Just hoping a share goes up for it future potential is not the best investing method, especially when that potential is 3 possibly years away and many hurdles along the way.
Agreed it looks interesting, but if they don’t sell the gold cash is needed imminently to do any trials in eu/us no?
When these aim bios raise cash it’s normally at a significantly lower price and a significant dilution. Once the funding question is out of the way and they get go ahead for trails, then it will feel safer.
Agreed it looks interesting, but if they don’t sell the gold cash is needed imminently to do any trials in eu/us no?
Just recently came across this, have some questions if anyone can help:
1) The phase 3 that was completed was only for Russia right? Therefore to get into the EU & US markets they will not only have to complete 2x phase 3 studies under EU/ US regulation, but it likely they will have to complete a phase2b first? Please correct me if I am wrong.
1) I see they own a large chunk of share in a gold company, however actual cash looks like they only actually have 1-2m? If that’s the case there will be a big raise coming/ dilution. 2m is no where near enough to run a phase 2 and then 2x phase 3 trials for for EU/US. Obviously the gold stock is worth a good amount which would help significantly, but is there any plan to sell it? I didn’t see anything?
While the drug seems promising, unless my initial understanding on the above is incorrect, it’s quite likely that there will be a large raise, or two, over the coming years, which means significant dilution. Also a phase 2b and 2x phase 3 trails will take years from now.
FYI 2 x phase 3 trails for EU/ US regulators is quite normal.
Any info will be much appreciated.
Also very surprised to see it bounce back, would have expected it to stay in low 40s and trade sideways for a week or so. Happy to see it bounce, shows there is strong demand. Could well break through 50 if the momentum keeps.
While I am certain nothing has leaked from trial because it’s too early and double blind trials are tighter then ducks ass, I do think there could be murmurs of potential tie ups, this is very possible.
Within the next 3-4 months we have expected news for: Phase 3 results, potential tie-ups/ licensing deals/ buyouts, TPR submissions and other TPR deals. A lot of potentially good info in such a short timeframe. Even TPR could cause a 100 % spike on the day. Good MED results and/or MED deals with another company and it could easily 5x from here.
Nothing is certain, but a good place to be at present.
My thoughts many months ago of this rising to minimum 50p, (50-100p), prior to results is almost there. With 50p share price, market cap will only be 100m, still quite cheap for the potential it has come nov/dec, only max 4 months away.
If it’s gets to the medium of my prediction ~ 75p, prior to results, that will be a great platform come results day. You only have to look at the previous companies on aim in similar position to understand.
Remember nothing goes up in a straight line so just be comfortable with the ups/ downs, especially when overall trend is a massive up!!!
ZK the fact that you post a smiley face with the idea of the price collapsing, shows your game...
Again, if you want to bash effectively, try and be subtle, don’t reveal your hand on the 3rd post with a massive ear to ear grin at a companies share price collapsing. I mean everyone is here to make money, but not sure everyone rejoices in other people’s potential losses as well as you.
For anyone that was on the fence as to weather ZK based his opinion of a price collapse to 18p, now you can be confident that his opinion is based on nothing more then the idea of being able to buy in cheap, possibly after selling higher, or making of a short spreadbet.
As well as that, neither ZK or hawk have yet been able to tell you any reasoning behind their prediction...keep up the good work boys. I don’t even need to be a ramper, you guys are doing such a shit job at deramping, your actually ramping hahaha
Hawk, another one posting for the sake of it. It’s only a contradiction if you don’t understand.
Over the next few months, BEFORE results, this will rise above 50p....maybe much further. I also said provided no unexpected negative news coming out of the woodworks. I am certain. I also said AFTER results, this will double or fall, dependant on the results. This is unknown until results day.
Between now and then it will rise on potential as shares do.
If you understood the markets at all you would not have written your post. What exactly do speculators/ day traders and Chartists do? They look for short term opportunity generally. These people are not stupid they can time the exit to maximise profit, and reenter on the retrace, and keep playing the cycle on the way up, or down.
In fact I don’t know why I am replying to you. Your post is so ridiculous that the 2 statements of mine you pasted are not even contradictory. Hahahaha. Whether I guarantee this will be above 50p before results or not, it doesn’t change the nature of short term day traders or Chartists. They will continue to try to time the market as they see fit.
Let’s just agree to disagree and wait and see
ZK how is it ramping? I guarantee you this will be above 50p (without any unforeseen bad news) in the coming couple months. I am not telling you to buy or anyone. Show me another company on AIM, where they had a potentially disruptive product, who’s market cap prior to its phase 3 read out, was this low? (~70m). That’s because investors, large and small, are willing to buy up to a point where they feel they don’t want to take more risk prior to the phase 3. This causes the share price to rise, normal market dynamics. Along the way day traders, speculators and institutions take profit, which is wise as nothing is guaranteed, and this causes the price to fall back for a couple of weeks. It will keep doing this until it reaches a point of equilibrium in which risk v reward is balanced for the ph3 read out. After phase 3 read out, that’s unknown, good news maybe 200% rise or more. Bad news or inconclusive data and it will fall.
I don’t have to have been in a share for several years to know where it is going over the next couple months, nor do I have had to have been in it for several years to post on this board.
You sound like an unhappy longtermer, who was either burnt and left or burnt and remains invested. Either way it’s understandable, as the the board have not made the best decisions in the past. Share prices don’t look to the past for their future movement. They look at potential and facts. At the moment this is moving on potential.
Why because if the results are good in a few months time, this will make a lot of people rich. If the results are good do you think FUM will be in control of MED for much longer. They will either hand over the product on a licensing deal or they will be bought out.
So it’s not ramping, the share price will continue in its trend. Where as you saying this is now going to drop into the teens is deramping is it not? As what are you basing that prediction on? It’s history or it’s potential future?
What an obvious idiot you are ZK. If you want do your job of deramping properly, maybe don’t be so fkn obvious. Don’t jump in when an obvious retrace is happening and preach doom.
Whether the results are good or bad in Nov/Dec, that doesn’t matter for the next few months. This will continue to rise until the risk v reward is balanced, and then some. Add to that the high chance of success with a known product already in use, TPR news hopefully by September, this will rise rapidly over the coming months.
A share price in the 30s is just too low, double it and then your talking. It will be a very bumpy ride though no doubt about that.
If you want to deramp properly, learn some human psychology and try to be less obvious, it may help with your strategy.
A example for you pumpkin, correct me where you think it’s wrong as it’s based on my understanding. Also I am going to be ultra conservative in both the number of daily users and the amount per serving that pxs could receive...(I think it’s ultra conservative, but again let me know if it isn’t).
20,0000,000 (daily users globally) x 365 days = 7.3bln (servings consumed/ annum) x £0.001 (1/10th of a penny profit to pxs per serving) = 7.3m revenue to pxs.
You can change around the numbers of global daily consumers or the profit to pxs per serving, but all entirely possible, IF they pull there fingers out and deliver.
Even with 2bln shares in issue, that kind of revenue could put pxs share price at 5-10p, dependant on what p/e you use.
So I agree with you in that it’s taken far too long, and it feels like Groundhog Day. But do you agree the above is not just possible, but entirely achievable with a good deal/ product in place with the likes of Byhealth or any large global?
Steady, exactly. it was more of a rhetorical question for pumpkin, who made out 2bln shares means pxs is dead in the water. We are no where near there of course, but it’s very easily doable with the right deals, even with 2bln shares in issue.
Good to see others, like yourself, still see the possibility....Still a high risk investment, to be made by those who are happy to take such risks
Sphinx, agreed. Apart from current sales and share price, which are shite, looks as though there is some grand plan going on in the background. I hope! Companies like DSM and BYhealth do not get involved and spend there own money for nothing.
A natural aspirin, smooths blood, blood pressure reduction, counteracting to pollution, etc....i would be gobsmacked if FF fell dead in the water!
Warren Buffett says, don’t buy if you are not willing to hold for 10yrs. I think many are close to that now, hopefully management will pull there fingers out and achieve what they have pointed to all this time.
Pumpkin, the calculator on your phone will help you work it out.
In case you don’t know how to use it, 3-10p would equate to approx 60-200m market cap. Now you answer me a question. What annual revenue would pxs need to produce to hit the low & top end of this estimate?
It was high a long time ago, but not now as I averaged down heavily over the years.
I believe this we get to somewhere between 3-10p, timescale I don’t know. And my range is so wide because I don’t know if pxs will be allowed to grow past a certain point before being taken out.
Some simple maths showing 10m, 20m, 50m, 100m daily users across the globe, it can be seen how pxs could achieve revenues of 5m-10m per annum. If they can get to that revenue then 10p share price entirely possible.
But all ifs at the moment, only management know what they are expecting to achieve, and what the long term strategy is on buy out etc.
Are you about 13 years old or something? This is a serious question as there is no way that an adult with any investment or even world experience would come up with such reasoning. ????????
Apart from that, you seem like a nice guy, and I agree with you that Provexis will come good one day, I am pretty certain on that. Many stars are alined with DSM, Byhealth, multiple uses including blood pressure. Apart from the revenue and share price, which are the main things for us investors.
I remain invested as I believe the tide will change, one day!
To see this has held nicely around 30p, hopefully the new floor. As I keep saying guys this will rise to minimum 50p+ over next few months, maybe even more. Market cap prior to read out will be somewhere around 150m-200m. Risk v reward ratio is far off still.
Also check out the monthly chart, over the past week it has finally gone into buy territory for the first time in almost 2 years! Good signal for a continued uptrend over the next 5 months until results.
GL guys ??